Breaking tolerance in the glomerulus: complement as a driver and therapeutic target in IgA nephropathy

Frontiers in Medicine

DOI: 10.3389/fmed.2026.1896069 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 0 stored of 0

References 7

IgA nephropathy
2023 Nature Reviews Disease Primers review Medicine Renal Diseases and Glomerulopathies Open access

246

citations
Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy
2020 Kidney International Reports article Medicine Renal Diseases and Glomerulopathies Open access cited by 18 patents

161

citations
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access

156

citations
Metabolic Flexibility and Innate Immunity in Renal Ischemia Reperfusion Injury: The Fine Balance Between Adaptive Repair and Tissue Degeneration
2020 Frontiers in Immunology article Medicine Acute Kidney Injury Research Open access

106

citations
Treatment of patients with IgA nephropathy: a call for a new paradigm
2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access

76

citations
IgA nephropathy: the lectin pathway and implications for targeted therapy
2023 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access

68

citations
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?
2021 Journal of Clinical Medicine article Immunology and Microbiology Complement system in diseases Open access

50

citations

7 results